Director: Global Development Lead
Director, Global Development Lead Late Stage Oncology / Radiopharma
I'm partnering with a fast‑growing, clinical‑stage biotech developing next‑generation radiopharmaceutical and biologic therapies. We're seeking a Director‑level Global Development Lead to drive one of the company's most important and highly resourced programs, a late‑stage asset entering global Phase 3 development.
This is a high‑visibility, high‑impact leadership opportunity for someone who thrives in both strategy and execution and who can hit the ground running from day one.
What You'll Own
- Serve as the Global Development Lead for a major late‑stage oncology program, shaping strategy and ensuring seamless execution across all development functions.
- Drive the successful advancement of the asset through Phase 3 and toward registration and commercialization.
- Lead global development planning across US, Japan, China, Latin America, and additional regions.
- Partner cross‑functionally with Clinical Operations, Regulatory, CMC, Commercial, Safety, and Program Leadership to ensure timelines, budgets, and deliverables track to plan.
- Represent the program to senior leadership with clear, proactive communication.
- Anticipate challenges and remove obstacles to maintain program velocity.
What You Bring
✔ Proven track record advancing therapies from early development through late‑stage clinical trials, ideally all the way to product launch.
✔ Hands‑on leadership of global Phase 3 trials, including multiple major regions (US + OUS).
✔ Ability to step in immediately, navigate complexity, and drive execution with confidence.
✔ Strength in both strategic leadership and operational oversight; you can zoom out and dive in.
Ideal Experience
- Radiopharmaceuticals
- Biologics
- Prostate cancer / oncology
- Previous leadership of a global Phase 3 oncology or radiopharma program
Why This Role Stands Out
- You will lead the company's largest and most strategically important program.
- Exceptional visibility with executive leadership and the board.
- A chance to shape the future of a rapidly advancing oncology pipeline.
- Competitive compensation package with meaningful equity.
If this sounds like a strong match or if you know someone outstanding, feel free to message me directly for a confidential conversation.